nevirapine has been researched along with Infant, Premature, Diseases in 2 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our study suggests that NVP dosing of preterm infants as soon as possible after birth without maternal intrapartum dosing may be as effective as combined maternal and infant dosing." | 1.37 | Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. ( Cotton, MF; Els, I; Hall, D; Madsen, R; Mirochnick, M; Mugabo, P; Rabie, H; Smith, J; Smith, P; Steyn, W, 2011) |
| "Transmission prophylaxis in offspring of HIV-positive mothers may give rise to adverse effects." | 1.34 | [Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants]. ( Bauer, K; Dunsch, D; Haberl, A; Linde, R; Reitter, A; Schlösser, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mugabo, P | 1 |
| Els, I | 1 |
| Smith, J | 1 |
| Rabie, H | 1 |
| Smith, P | 1 |
| Mirochnick, M | 1 |
| Steyn, W | 1 |
| Hall, D | 1 |
| Madsen, R | 1 |
| Cotton, MF | 1 |
| Schlösser, R | 1 |
| Linde, R | 1 |
| Dunsch, D | 1 |
| Reitter, A | 1 |
| Haberl, A | 1 |
| Bauer, K | 1 |
2 other studies available for nevirapine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Female; HIV-1; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Disea | 2011 |
[Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cesarean Section; Female; Gestational Age; HIV | 2007 |